|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C12P 21/00 | (2006.01) | ||
| C12P 21/08 | (2006.01) |
| (11) | Number of the document | 3337502 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16837818.0 |
| Date of filing the European patent application | 2016-08-18 | |
| (97) | Date of publication of the European application | 2018-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-24 |
| (46) | Date of publication of the claims translation | 2020-09-25 |
| (86) | Number | PCT/US2016/047506 |
| Date | 2016-08-18 |
| (87) | Number | WO 2017/031288 |
| Date | 2017-02-23 |
| (30) | Number | Date | Country code |
| 201562207164 P | 2015-08-19 | US |
| (72) |
DEPAZ, Roberto, US
DEJESUS, Natalie, US
BEE, Jared, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Stabili kompozicija prieš IFNAR1 |
| STABLE ANTI-IFNAR1 FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2024-07-18 | 9 | 208.00 EUR |
| 2025-08-18 |